Home/Immunethep/Pedro Madureira
PM

Pedro Madureira

CSO & Co-Founder

Immunethep

Immunethep Pipeline

DrugIndicationPhase
E. coli VaccinePrevention of E. coli infectionsPreclinical
Monoclonal Antibodies ProgrammeTherapeutic for bacterial infection (unspecified)Preclinical